LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 11388

Search options

  1. Book ; Online: Laser Additive Manufacturing: Design, Materials, Processes and Applications

    Yin, Jie / Liu, Yang / Zhao, Ping

    2023  

    Keywords Technology: general issues ; History of engineering & technology ; Mg-Zn solid solution ; laser sintering ; mechanical alloying ; corrosion resistance ; directed energy deposition ; additive manufacturing ; bimetal ; analytical model ; printability maps ; femtosecond laser ; hyaluronic acid methacryloyl ; polyethylene glycol diacrylate ; stimuli-responsiveness ; selective laser melting ; laser powder bed fusion ; Ti-6Al-4V ; heat treatment ; annealing ; laser cutting ; non-contact process ; neutron tube shells ; 304 stainless steel ; fiber laser ; thermal transmission simulation ; dynamic behaviors ; porosity ; spall ; NiTi alloy ; CuSn10 alloy ; dissimilar materials ; interfacial bonding properties ; laser material deposition ; pulse wave laser ; temperature field simulation ; surface quality ; microstructural features ; corrosion behavior ; laser melting injection ; W particles ; Al alloys ; wear ; iron bone implant ; zinc sulfide ; degradation properties ; passivation film ; thermal management materials ; titanium-coated diamond/copper composites ; copper-coated diamond/copper composites ; selective laser sintering ; carbon fiber reinforced polyamide composites ; strain rate ; hygroscopicity ; additively manufacture ; 17-4PH stainless steel ; laser additive manufacturing ; Poisson's ratio ; anti-tetrachiral stents ; biocompatibility ; spatter ; in situ detection ; generation mechanism ; detrimental effects ; counter-measures ; compression ; microstructure transformation ; dislocation pinning ; recovery ability ; n/a
    Language English
    Size 1 electronic resource (270 pages)
    Publisher MDPI - Multidisciplinary Digital Publishing Institute
    Publishing place Basel
    Document type Book ; Online
    Note English
    HBZ-ID HT030375626
    ISBN 9783036560694 ; 3036560696
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  2. Article ; Online: Effect of Acceptance and Commitment Therapy Combined with Music Relaxation Therapy on the Self-Identity of College Students.

    Yin, Jing

    publication RETRACTED

    Journal of healthcare engineering

    2022  Volume 2022, Page(s) 8422903

    Abstract: This paper analyzes various effects of acceptance and commitment therapy combined with music relaxation therapy on the self-identity of the college students. Through open recruitment and following the principle of voluntary and confidential, 80 college ... ...

    Abstract This paper analyzes various effects of acceptance and commitment therapy combined with music relaxation therapy on the self-identity of the college students. Through open recruitment and following the principle of voluntary and confidential, 80 college students were selected from our school, and then they were divided into two groups: the control group (40 cases) and the observation group (40 cases). The observation group received acceptance and commitment therapy combined with music relaxation therapy. For the control group, conventional mental health interventions were administered. Two months after intervention, psychological status, mental resilience, and quality of life scores were compared between the two groups. Before intervention, there was no significant difference in SAS and SDS scores between the two groups (
    MeSH term(s) Acceptance and Commitment Therapy ; Humans ; Music ; Quality of Life ; Relaxation Therapy ; Students
    Language English
    Publishing date 2022-02-10
    Publishing country England
    Document type Journal Article ; Retracted Publication
    ZDB-ID 2545054-2
    ISSN 2040-2309 ; 2040-2295
    ISSN (online) 2040-2309
    ISSN 2040-2295
    DOI 10.1155/2022/8422903
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Fabrication of a Modified Polyethersulfone Membrane with Anti-Fouling and Self-Cleaning Properties from SiO

    Yin, Jun

    Polymers

    2022  Volume 14, Issue 11

    Abstract: To prepare anti-fouling and self-cleaning membrane material, a physical blending modification combined with surface grafting modification has been carried out; first, poly (2-hydroxyethyl methacrylate) grafted silica nanoparticles ( ... ...

    Abstract To prepare anti-fouling and self-cleaning membrane material, a physical blending modification combined with surface grafting modification has been carried out; first, poly (2-hydroxyethyl methacrylate) grafted silica nanoparticles (SiO
    Language English
    Publishing date 2022-05-27
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2527146-5
    ISSN 2073-4360 ; 2073-4360
    ISSN (online) 2073-4360
    ISSN 2073-4360
    DOI 10.3390/polym14112169
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book ; Online: Interactions Between Diets, Gut Microbiota and Host Metabolism

    Yin, Jie / Xie, Liwei / Luo, Yuheng / Oz, Helieh S.

    2020  

    Keywords Medicine ; Dietetics & nutrition ; diets ; gut microbiota ; host metabolism ; dysbiosis ; metagenomics ; metabolomics
    Size 1 electronic resource (595 pages)
    Publisher Frontiers Media SA
    Document type Book ; Online
    Note English ; Open Access
    HBZ-ID HT021231544
    ISBN 9782889639984 ; 2889639983
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  5. Article: [Interpretation of Chinese guideline on the diagnosis and management of thrombotic thrombocytopenic purpura (2022)].

    Yin, J / Yu, Z Q

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

    2022  Volume 43, Issue 1, Page(s) 16–18

    MeSH term(s) ADAMTS13 Protein ; Asians ; China ; Humans ; Plasma Exchange ; Purpura, Thrombotic Thrombocytopenic/diagnosis ; Purpura, Thrombotic Thrombocytopenic/therapy
    Chemical Substances ADAMTS13 Protein (EC 3.4.24.87)
    Language Chinese
    Publishing date 2022-01-21
    Publishing country China
    Document type Journal Article
    ZDB-ID 2997162-7
    ISSN 0253-2727 ; 0253-2727
    ISSN (online) 0253-2727
    ISSN 0253-2727
    DOI 10.3760/cma.j.issn.0253-2727.2022.01.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: [Interpretation of Chinese guideline on the diagnosis and management of von Willebrand disease (2022)].

    Yin, J / Yu, Z Q

    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

    2022  Volume 43, Issue 1, Page(s) 13–15

    MeSH term(s) Asians ; China ; Humans ; von Willebrand Diseases/diagnosis ; von Willebrand Diseases/therapy ; von Willebrand Factor
    Chemical Substances von Willebrand Factor
    Language Chinese
    Publishing date 2022-01-21
    Publishing country China
    Document type Journal Article
    ZDB-ID 2997162-7
    ISSN 0253-2727 ; 0253-2727
    ISSN (online) 0253-2727
    ISSN 0253-2727
    DOI 10.3760/cma.j.issn.0253-2727.2022.01.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: State of the Art in 2022 PET/CT in Breast Cancer: A Review.

    Zhang-Yin, Jules

    Journal of clinical medicine

    2023  Volume 12, Issue 3

    Abstract: Molecular imaging with positron emission tomography is a powerful and well-established tool in breast cancer management. In this review, we aim to address the current place of the main PET radiopharmaceuticals in breast cancer care and offer perspectives ...

    Abstract Molecular imaging with positron emission tomography is a powerful and well-established tool in breast cancer management. In this review, we aim to address the current place of the main PET radiopharmaceuticals in breast cancer care and offer perspectives on potential future radiopharmaceutical and technological advancements. A special focus is given to the following: the role of
    Language English
    Publishing date 2023-01-27
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662592-1
    ISSN 2077-0383
    ISSN 2077-0383
    DOI 10.3390/jcm12030968
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Advances in corneal graft rejection.

    Yin, Jia

    Current opinion in ophthalmology

    2021  Volume 32, Issue 4, Page(s) 331–337

    Abstract: Purpose of review: Immune rejection after corneal transplantation is a major risk for graft failure. We aim to summarize recent advances in the understanding and management of graft rejection.: Recent findings: Immune rejection remains the leading ... ...

    Abstract Purpose of review: Immune rejection after corneal transplantation is a major risk for graft failure. We aim to summarize recent advances in the understanding and management of graft rejection.
    Recent findings: Immune rejection remains the leading cause of graft failure in penetrating keratoplasty (PKP). While ABO blood type and sex match between donor and recipient may reduce rejection, human leucocyte antigens class II matching in a randomized study did not reduce the risk of rejection in high-risk PKP. Compared with PKP, deep anterior lamellar keratoplasty, descemet stripping automated endothelial keratoplasty, and descemet membrane endothelial keratoplasty have lower immune rejection rates of 1.7-13%, 5-11.4%, and 1.7-2.8%, respectively, based on long-term (5 years and more) studies. Whether immune rejection is a major risk factor for graft failure in these lamellar keratoplasties is unclear. While there have not been major advances in the systemic management of graft rejection, topical nonsteroid agents such as tacrolimus and anti-vascular endothelial growth factor have shown promise in high-risk cases.
    Summary: Immune rejection remains the leading cause of graft failure in PKP. Lamellar keratoplasties have significantly lower rejection rates compared with PKP. The significance of rejection in the failure of lamellar grafts warrants further investigation.
    MeSH term(s) Corneal Diseases/surgery ; Corneal Transplantation/adverse effects ; Graft Rejection/immunology ; Graft Survival ; Humans ; Immunity, Cellular ; Risk Factors ; Tissue Donors
    Language English
    Publishing date 2021-05-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1049383-9
    ISSN 1531-7021 ; 1040-8738
    ISSN (online) 1531-7021
    ISSN 1040-8738
    DOI 10.1097/ICU.0000000000000767
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: New advances in the treatment of chondrosarcoma under the PD-1/PD-L1 pathway.

    Yin, Jiawei / Ren, Peng

    Journal of cancer research and therapeutics

    2024  Volume 20, Issue 2, Page(s) 522–530

    Abstract: Abstract: Bone sarcomas encompass a group of spontaneous mesenchymal malignancies, among which osteosarcoma, Ewing sarcoma, chondrosarcoma, and chordoma are the most common subtypes. Chondrosarcoma, a relatively prevalent malignant bone tumor that ... ...

    Abstract Abstract: Bone sarcomas encompass a group of spontaneous mesenchymal malignancies, among which osteosarcoma, Ewing sarcoma, chondrosarcoma, and chordoma are the most common subtypes. Chondrosarcoma, a relatively prevalent malignant bone tumor that originates from chondrocytes, is characterized by endogenous cartilage ossification within the tumor tissue. Despite the use of aggressive treatment approaches involving extensive surgical resection, chemotherapy, and radiotherapy for patients with osteosarcoma, chondrosarcoma, and chordoma, limited improvements in patient outcomes have been observed. Furthermore, resistance to chemotherapy and radiation therapy has been observed in chondrosarcoma and chordoma cases. Consequently, novel therapeutic approaches for bone sarcomas, including chondrosarcoma, need to be uncovered. Recently, the emergence of immunotherapy and immune checkpoint inhibitors has garnered attention given their clinical success in various diverse types of cancer, thereby prompting investigations into their potential for managing chondrosarcoma. Considering that circumvention of immune surveillance is considered a key factor in the malignant progression of tumors and that immune checkpoints play an important role in modulating antitumor immune effects, blockers or inhibitors targeting these immune checkpoints have become effective therapeutic tools for patients with tumors. One such checkpoint receptor implicated in this process is programmed cell death protein-1 (PD-1). The association between PD-1 and programmed cell death ligand-1 (PD-L1) and cancer progression in humans has been extensively studied, highlighting their remarkable potential as biomarkers for cancer treatment. This review comprehensively examines available studies on current chondrosarcoma treatments and advancements in anti-PD-1/PD-L1 blockade therapy for chondrosarcoma.
    MeSH term(s) Humans ; Chondrosarcoma/therapy ; Chondrosarcoma/pathology ; Chondrosarcoma/metabolism ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/metabolism ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism ; Bone Neoplasms/pathology ; Bone Neoplasms/therapy ; Bone Neoplasms/metabolism ; Bone Neoplasms/immunology ; Bone Neoplasms/drug therapy ; Immune Checkpoint Inhibitors/therapeutic use ; Immune Checkpoint Inhibitors/pharmacology ; Immunotherapy/methods
    Chemical Substances B7-H1 Antigen ; Programmed Cell Death 1 Receptor ; CD274 protein, human ; PDCD1 protein, human ; Immune Checkpoint Inhibitors
    Language English
    Publishing date 2024-04-30
    Publishing country India
    Document type Journal Article ; Review
    ZDB-ID 2187633-2
    ISSN 1998-4138 ; 0973-1482
    ISSN (online) 1998-4138
    ISSN 0973-1482
    DOI 10.4103/jcrt.jcrt_2269_23
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Economic value of toripalimab plus axitinib as first-line treatment for advanced renal cell carcinoma in China: a model-based cost-effectiveness analysis.

    Kang, Shuo / Yin, Jintuo

    Expert review of pharmacoeconomics & outcomes research

    2024  , Page(s) 1–7

    Abstract: Objective: The current analysis aimed to evaluate the economic benefit of toripalimab plus axitinib for previously untreated RCC patients from the Chinese healthcare system perspective.: Methods: The partitioned survival model was developed to ... ...

    Abstract Objective: The current analysis aimed to evaluate the economic benefit of toripalimab plus axitinib for previously untreated RCC patients from the Chinese healthcare system perspective.
    Methods: The partitioned survival model was developed to simulate 3-week patients' transition in 20-year time horizon to evaluate the cost-effectiveness of toripalimab plus axitinib compared with sunitinib for advanced RCC. Survival data were gathered from the RENOTORCH trial, and cost and utility inputs were obtained from the database and published literature. Total cost, life-years (LYs), quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER) were the model outputs. Subgroup analyses and sensitivity analyses were conducted to increase the comprehensiveness and estimate the robustness of the model results.
    Results: In the base-case analysis, compared with sunitinib, toripalimab plus axitinib could bring additional 1.19 LYs and 0.65 QALYs, with the marginal cost of $41,499.23, resulting in the ICER of $64,337.49/QALY, which is higher than the WTP threshold. And ICERs were always beyond the WTP threshold of all subgroups. Sensitivity analyses demonstrated the model results were robust.
    Conclusions: Toripalimab plus axitinib was unlikely to be the cost-effective first-line therapy for patients with previously untreated advanced RCC compared with sunitinib from the Chinese healthcare system perspective.
    Language English
    Publishing date 2024-03-21
    Publishing country England
    Document type Journal Article
    ZDB-ID 2208481-2
    ISSN 1744-8379 ; 1473-7167
    ISSN (online) 1744-8379
    ISSN 1473-7167
    DOI 10.1080/14737167.2024.2333334
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top